🇺🇸 FDA
Patent

US 9446010

Compounds and methods for treating aberrant adrenocortical cell disorders

granted A61KA61K31/03A61K31/155

Quick answer

US patent 9446010 (Compounds and methods for treating aberrant adrenocortical cell disorders) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/03, A61K31/155, A61K31/17, A61K31/436